This content is restricted to site members. If you are an existing user, please log in. New users may register below.
VISTABEL® receives Europe’s first Positive Opinion for the treatment of crow’s feet in adults
This month, Allergan Inc. announced that VISTABEL® has received a Positive Opinion from the Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM) for the temporary improvement in